Search
Penumbra Inc
PENAdd to Watchlist
321.190USD
+1.430+0.45%
Close 07-31 16:00（ET）Quotes delayed by 15 min
12.65BMarket Cap
73.36P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Penumbra Inc is 6.63, ranking 164 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 320.00, with a high of 355.00 and a low of 266.00.
Analyst Rating
Based on
16
analysts
Hold
Current Rating
368.533
Target Price
+15.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Penumbra Inc
PEN
16
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Penumbra Inc's expected revenue for the next quarter?
Penumbra Inc's expected revenue is 402.10M.
What is Penumbra Inc's price target?
Analysts forecast that Penumbra Inc's price target is USD 320.00, with the highest forecast at USD 355.00 and the lowest forecast at USD 266.00.
How have Penumbra IncPEN's recent earnings per share performed?
The market expectation was USD 0.88, while Penumbra IncPEN's earnings per share (EPS) for the previous quarter was USD 0.83. EPS for the next quarter is expected at USD 1.30.
What is the analyst rating for Penumbra Inc?
Based on the ratings of Penumbra Inc's stock from 16 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.